PFS and Injectable Drug Devices East Coast

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including:

Device Innovations for Large Volume and Novel Drug Product Delivery
Advancing Sustainability in the Injectable Device Industry
Primary Packaging: Ensuring Safe, Stable, and Biocompatible Combination Products
Patient-Driven Device Design

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Speakers: Mark Howansky VP, Device Development and Commercialization, Viridian Therapeutics, Theresa Scheuble Director R and D Drug Delivery Systems, Johnson and Johnson, Amin Sedighiamiri Senior Director, Device Development and Technology, Merck, Monica Swinney Sr. Director and Head, Drug Delivery Innovation and New Product Planning, Gilead Sciences, Sujit Basu Vice President and Head, Pharmaceutical Development, Ionis Pharmaceuticals, Mark DeStefano Global Technology Innovation, Combination Products and Device Research and Development, Teva Pharmaceuticals